Success Metrics

Clinical Success Rate
100.0%

Based on 26 completed trials

Completion Rate
100%(26/26)
Active Trials
0(0%)
Results Posted
38%(10 trials)

Phase Distribution

Ph phase_4
11
37%
Ph not_applicable
14
47%
Ph phase_3
2
7%

Phase Distribution

0

Early Stage

0

Mid Stage

13

Late Stage

Phase Distribution27 total trials
Phase 3Large-scale testing
2(7.4%)
Phase 4Post-market surveillance
11(40.7%)
N/ANon-phased studies
14(51.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

26 of 26 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

30

all time

Status Distribution
Active(1)
Completed(26)
Other(3)

Detailed Status

Completed26
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (7.4%)
Phase 411 (40.7%)
N/A14 (51.9%)

Trials by Status

not_yet_recruiting13%
unknown310%
completed2687%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT06414018Not Applicable

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

Completed
NCT06212622

Is the Rate of Early Mobilisation in Hip Fracture Patients Using Alfentanil Better Than Standard Opioid Analgesia?

Completed
NCT06563297Phase 4

To Explore the Optimal Dose of Alfentanil for Skull Pin Fixation in Intracranial Surgery

Not Yet Recruiting
NCT05525351

The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia

Unknown
NCT03813875

Modeling and Application of Triple Drug Response Surface Models

Completed
NCT03359395Phase 4

Pre-medication With Alfentanil vs Placebo During ECT

Completed
NCT01008059Not Applicable

Alfentanil: Simultaneous Testing Pilot

Completed
NCT02625181Not Applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Completed
NCT01371968Not Applicable

Optimal Dose of Alfentanil for Removal of Supreme Laryngeal Mask Airway During Emergence From Desflurane Anaesthesia

Completed
NCT00991809Not Applicable

Study on the Development of Opioid Induced Hyperalgesia (OIH) After Exposure to Alfentanil

Completed
NCT02646592Not Applicable

Effect of a Bolus of 10 µg/kg of Alfentanil on the Pupillary Pain Index

Completed
NCT01094574Not Applicable

Evaluation of Propranolol's Effect on Pain and Inflammation.

Completed
NCT00997126Phase 4

Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation

Completed
NCT00672438Not Applicable

Heritability of Opioid Effects: A Twin Study

Completed
NCT01199458Phase 4

The Effect of an Opioid on the Lower Esophageal Sphincter During Anesthesia Induction

Completed
NCT02358057Phase 4

Can we Get Conscious Sedation by Combining Dexmedetomidine With Alfentanil?

Completed
NCT02267681Phase 4

Opioid Effects on Cognitive Function Following Colonoscopy

Completed
NCT01470170Phase 4

Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy

Completed
NCT02486926Not Applicable

The Effects of Remifentanil and Remifentanil-Alfentanil Administration in Children

Completed
NCT01049672Not Applicable

Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients?

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30